Abstract
Interventions for renal arterial disease are primarily driven by functional consequences of the disease. These are poorly controlled hypertension, increasing renal dysfunction (often associated with loss of renal mass), and, more recently, control of congestive heart failure. The dominant causes are atherosclerotic stenosis and fibromuscular dysplasia. Good interventional technique allows for precise definition of the lesions, safe intervention, and appropriate interpretation of the end result. Strict adherence to the gold standard indications for intervention results in good long-term functional results.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Conlon PJ, Athirakul K, Kovalik E, et al. Survival in renal vascular disease. J Am Soc Nephrol. 1998;9:252–6.
Rossi GP, Rossi A, Zanin L, et al. Excess prevalence of extracranialcarotid artery lesions in renovascular hypertension. Am J Hypertens. 1992;5:8–15.
Louie J, Isaacson JA, Zierler RE, et al. Prevalence of carotid and lower extremity arterial disease in patients with renal artery stenosis. Am J Hypertens. 1994;7:436–9.
Valentine RJ, Myers SI, Miller GL, et al. Detection of unsuspected renal artery stenoses in patients with abdominal aortic aneurysms: refined indications for preoperative aortography. Ann Vasc Surg. 1993;7:220–4.
Zierler RE, Bergelin RO, Polissar NL, et al. Carotid and lower extremity disease in patients with renal artery atherosclerosis. Arch Intern Med. 1998;158:761–7.
Choudhri AH, Cleland JGF, Rowlands PC, et al. Unsuspected renal artery stenosis in peripheral vascular disease. Br Med J. 1990;301:1197–8.
Olin JW, Melia M, Young JR, et al. Prevalence of renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990;88:46N–51.
Miralles M, Corominas A, Cotillas J, et al. Screening for carotid and renal artery stenoses in patients with aortoiliac disease. Ann Vasc Surg. 1998;12:17–21.
Eyler WR, Clarck MD, Garman JE, et al. Angiography of the renal arteries including a comparative study of renal artery stenoses inpatients with and without hypertension. Radiology. 1962;78:879–92.
Holley KE, Hunt JC, Brown AL, et al. Renal artery stenosis. A clinical-pathologic study in normotensive and hypertensive patients. Am J Med. 1964;37:14–22.
Caps MT, Perissinotto C, Zierler RE, Polissar NL, Bergelin RO, Tullis MJ. Prospective study of atherosclerotic disease progression in the renal artery. Circulation. 1998;98(25):2866–72.
Caps MT, Zierler RE, Polissar NL, et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int. 1998;53(3):735–42.
Martin LG, Rundback JH, Sacks D, Cardella JF, Rees CR, Matsumoto AH. Quality improvement guidelines for angiography, angioplasty, and stent placement in the diagnosis and treatment of renal artery stenosis in adults. J Vasc Interv Radiol. 2003;14:S297–310.
Zeller T, Frank U, Muller C, et al. Technological advances in the design of catheters and devices used in renal artery interventions: impact on complications. J Endovasc Ther. 2003;10:1006–14.
Sivamurthy N, Suroweic SM, Culakova E, et al. Divergent outcomes after percutaneous therapy for symptomatic renal artery stenosis. J Vasc Surg. 2004;39:565–74.
Zierler RE, Bergelin RO, Davidson RC, Cantwell-Gab K, Polissar NL, Strandness Jr DE. A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens. 1996;9:1055–61.
Yutan E, Glickerman DJ, Caps MT, Hatsukami T, Harley JD, Davies MG. Percutaneous transluminal revascularization for renal artery stenosis: Veterans Affairs Puget Sound Health Care System experience. J Vasc Surg. 2001;34:685–93.
Galaria II, Surowiec SM, Rhodes JM, et al. Percutaneous and open renal revascularizations have equivalent long-term functional outcomes. Ann Vasc Surg. 2005;19(2):218–28.
Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology. 2000;216:78–85.
Plouin PF, Chatellier G, Darne B, Raynoud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31:823–9.
Hoffman O, Carreres T, Sapoval MR, et al. Ostial renal artery stenosis angioplasty: immediate and mid-term angiographic and clinical results. J Vasc Interv Radiol. 1998;9:65–73.
Jensen G, Zachrisson BF, Delin K, Volkmann R, Aurell M. Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int. 1995;48:1936–45.
Chatziioannou A, Mourikis D, Agroyannis B, et al. Renal artery stenting for renal insufficiency in solitary kidney in 26 patients. Eur J Vasc Endovasc Surg. 2002;23:49–54.
Cioni R, Vignali C, Petruzzi P, et al. Renal artery stenting in patients with a solitary functioning kidney. Cardiovasc Intervent Radiol. 2001;24(6):372–7.
Taylor A, Sheppard D, MacLeod MJ, et al. Renal artery stent placement in renal artery stenosis: technical and early clinical results. Clin Radiol. 1997;52:451–7.
Lederman RJ, Mendelsohn FO, Santos R, Phillips HR, Stack RS, Crowley J. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J. 2001;142:314–23.
Dorros G, Jaff M, Mathiak L. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renalartery stenosis. Circulation. 1998;98:642–7.
Rocha-Singh KJ, Ahuja RK, Sung CH, Rutherford J. Long-term renal function preservation after renal artery stenting in patientswith progressive ischemic nephropathy. Catheter Cardiovasc Interv. 2002;57:135–41.
Hennequin LM, Joffre FG, Rousseau HP, et al. Renal artery stent placement: long-term results with the Wallstent endoprosthesis. Radiology. 1994;191:713–9.
Davies MG, Bismuth J, Saad WE, Naoum JJ, Peden EK, Lumsden AB. Impact of metabolic syndrome on the outcomes of percutaneous renal angioplasty and stenting. J Vasc Surg. 2010;51:926–32.
Dejani H, Eisen TD, Finkelstein FO. Revascularization of renal artery stenosis in patients with renal insufficiency. Am J Kidney Dis. 2000;36(4):752–8.
Beek FJ, Kaatee R, Beutler JJ, van der Ven PJ, Mali WP. Complications during renal artery stent placement for atherosclerotic ostial stenosis. Cardiovasc Intervent Radiol. 1997;20:184–90.
Boisclair C, Therasse E, Oliva VL, et al. Treatment of renal angioplasty failure by percutaneous renal artery stenting with Palmaz stents: midterm technical and clinical results. Am J Roentgenol. 1997;681(1):245–51.
White CJ. Catheter-based therapy for atherosclerotic renal artery stenosis. Circulation. 2006;113:1464–73.
Bates MC, Rashid M, Campbell JE, Stone PA, Broce M, Lavigne PS. Factors influencing the need for target vessel revascularization after renal artery stenting. J Endovasc Ther. 2006;13(5):569–77.
Blum U, Krumme B, Flügel P, et al. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med. 1997;336(7):459–65.
Abizaid A, Kornowski R, Mintz GS, et al. The influence of diabetes mellitus on acute and late outcomes following coronary stent implantation. J Am Coll Cardiol. 1998;32:584–9.
Carter AJ, Bailey L, Devries J, Hubbard B. The effects of uncontrolled hyperglycemia on thrombosis and formation of neoinitma after coronary stent placement in a novel diabetic porcine model of restenosis. Coron Artery Dis. 2000;11:473–9.
Davies MG, Saad WE, Bismuth J, Peden EK, Naoum JJ, Lumsden AB. Outcomes of endoluminal re-intervention for restenosis after percutaneous renal angioplasty and stenting. J Vasc Surg. 2009;49:946–52.
Rees CR, Palmaz JC, Becker GJ, et al. Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: preliminary report of a multicenter study. Radiology. 1991;181:507–14.
Baumgartner I, von Aesch K, Do DD, Triller J, Birrer M, Mahler F. Stent placement in ostial and nonostial atherosclerotic renal arterial stenoses: a prospective follow-up study. Radiology. 2000;216:498–505.
Pearce JD, Craven BL, Craven TE, et al. Progression of atherosclerotic renovascular disease: a prospective population-based study. J Vasc Surg. 2006;44(5):955–63.
Cherr GS, Hansen KJ, Craven TE, et al. Surgical management of atherosclerotic renovascular disease. J Vasc Surg. 2002;35(2):236–45.
Hansen KJ, Cherr GS, Craven TE, et al. Management of ischemic nephropathy: dialysis-free survival after surgical repair. J Vasc Surg. 2000;32(3):472–82.
Oskin TC, Hansen KJ, Deitch JS, Craven TE, Dean RH. Chronic renal artery occlusion: nephrectomy versus revascularization. J Vasc Surg. 1999;29(1):140–9.
Davies MG, Saad WE, Bismuth JX, Peden EK, Naoum JJ, Lumsden AB. Endovascular revascularization of renal artery stenosis in the solitary functioning kidney. J Vasc Surg. 2009;49:953–60.
Protack CD, Bakken AM, Saad WE, Davies MG. Renal artery interventions during EVAR: a greater potential of subsequent failure? J Vasc Interv Radiol. 2010;21(4):459–64.
Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344(6):431–42.
Leadbetter WF, Burkland CE. Hypertension in unilateral renal disease. J Urol. 1938;39:611.
Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004;350:1862–71.
Ekelund L, Gerlock J, Molin J, Smith C. Roentgenologic appearance of fibromuscular dysplasia. Acta Radiol Diagn. 1978;19(3):433–46.
Goncharenko V, Gerlock AJJ, Shaff MI, Hollifield JW. Progression of renal artery fibromuscular dysplasia in 42 patients as seen on angiography. Radiology. 1981;139:45–51.
Fernando D, Garasic J. Percutaneous intervention for renovascular disease rationale and patient selection. Curr Opin Cardiol. 2004;19:582–8.
Birrer M, Do DD, Mahler F, et al. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg. 2002;23(2):146–52.
Sos TA, Pickering TG, Sniderman K, et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med. 1983;309:274–9.
Surowiec SM, Sivamurthy N, Rhodes JM, et al. Percutaneous therapy for renal artery fibromuscular dysplasia. Ann Vasc Surg. 2003;17(6):650–5.
Davidson RA, Barri Y, Wilcox CS. Predictors of cure of hypertension in fibromuscular renovascular disease. Am J Kidney Dis. 1996;28:334–8.
Bonelli FS, McKusick MA, Textor SC, et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients [see comment]. Mayo Clinic Proc. 1995;70:1041–52.
Tegtmeyer CJ, Selby JB, Harlwell GD, Ayers C, Tegtmeyer V. Results and complications of angioplasty in fibromuscular disease. Circulation. 1991;83(2 Suppl):I155–61.
Baert AL, Wilms G, Amery A, Vermylen J, Suy R. Percutaneous transluminal renal angioplasty: initial results and long-term follow-up in 202 patients. Cardiovasc Intervent Radiol. 1990;13:22–8.
Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg. 2003;38(5):962–8.
Holden A, Hill A, Jaff MR, Pilmore H. Renal artery stent revascularization with embolic protection in patients with ischemic nephropathy. Kidney Int. 2006;70(5):830–2.
Edwards MS, Corriere MA, Craven TE, et al. Atheroembolism during percutaneous renal artery revascularization. J Vasc Surg. 2007;46(1):55–61.
Kane GC, Textor SC, Schirger A, et al. Factors associated with restenosis in women following percutaneous renal artery revascularization for hypertension. Am J Hypertens. 2003;16:252A–3.
Oertle M, Do DD, Baumgartner I, Triller J, Mahler F. Discrepancy of clinical and angiographic results in the follow-up of percutaneous transluminal renal angioplasty. Vasa. 1998;27:154–7.
Edwards MS, Craven BL, Stafford J, et al. Distal embolic protection during renal artery angioplasty and stenting. J Vasc Surg. 2006;44:128–35.
Novick AC. Management of renovascular disease: a surgical perspective. Circulation. 1991;83:167–71.
Louden JD, Leen GLS, Cove-Smith R. Systemic thrombolysis for bilateral atherosclerotic renal artery occlusion resulting in prolonged recovery of renal function. Nephrol Dial Transplant. 1998;13:2924–6.
Olin JW, Graor RA, Young JR. Thrombolytic therapy for renal artery occlusions: a preliminary report. Cleve Clin J Med. 1989;56(4):432–8.
Buri P. Acute renal artery occlusion. Origin, diagnosis, possibilities of treatment. Schweiz Med Wochenschr. 1975;105(30):941–8.
Fiala LA, Jackson MR, Gillespie DL, et al. Primary stenting of atherosclerotic renal artery ostial stenosis. Ann Vasc Surg. 1998;12:128–33.
Ivanovic V, McKusick M, Johnson III CM, et al. Renal artery stent placement: complications at a single tertiary care center. J Vasc Interv Radiol. 2003;14:217–25.
Beek FJ, Kaatee R, Beutler JJ, et al. Complications during renal artery stent placement for atherosclerotic ostial stenosis. Cardiovasc Intervent Radiol. 1997;20:184–90.
Bloch MJ, Trost DW, Sos TA. Type B aortic dissection complicating renal artery angioplasty and stent placement. J Vasc Interv Radiol. 2001;12:517–20.
Haesemeyer SW, Vedantham S, Braverman A. Renal artery stent placement complicated by development of a type B aortic dissection. Cardiovasc Intervent Radiol. 2005;28:98–101.
Morris CS, Bonnevie GJ, Najarian KE. Nonsurgical treatment of acute iatrogenic renal artery injuries occurring after renal artery angioplasty and stenting. AJR Am J Roentgenol. 2001;177:1353–7.
Peterson RA, Baldauf CG, Millward SF, et al. Outpatient percutaneous transluminal renal artery angioplasty: a Canadian experience. J Vasc Interv Radiol. 2000;11:327–32.
Axelrod DJ, Freeman H, Pukin L, et al. Guidewire perforation leading to fatal perirenal hemorrhage from transcortical collaterals after renal artery stent placement. J Vasc Interv Radiol. 2004;15:985–7.
Elliott SP, Olweny EO, McAninch JW. Renal arterial injuries: a single center analysis of management strategies and outcomes. J Urol. 2007;178(8):2451–5.
Chua SK, Hung HF. Renal artery stent fracture with refractory hypertension: a case report and review of the literature. Catheter Cardiovasc Interv. 2009;74(1):37–42.
Breyer BN, McAninch JW, Elliott SP, Master VA. Minimally invasive endovascular techniques to treat acute renal hemorrhage. J Urol. 2008;179(6):2248–52.
Phadke RV, Sawlani V, Rastogi H, et al. Iatrogenic renal vascular injuries and their radiological management. Clin Radiol. 1997;52(2):119–23.
Cimsit NC, Baltacioglu F, Cengic I, Akpinar IN, Ilker Y, Turkeri L. Transarterial glue embolization in iatrogenic renovascular injuries. Int Urol Nephrol. 2008;40(4):875–9.
Schillinger M, Haumer M, Mlekusch W, Schlerka G, Ahmadi R, Minar E. Predicting renal failure after balloon angioplasty in high-risk patients. J Endovasc Ther. 2001;8(6):609–14.
Beutler JJ, Van Ampting JMA, van de Ven PJG, et al. Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Nephrol. 2001;12:1475–81.
Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. Implications of acute renal injury following percutaneous renal artery intervention. Ann Vasc Surg. 2008;22(6):783–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag London
About this chapter
Cite this chapter
Vykoukal, D., Anaya-Ayala, J.E., Davies, M.G. (2012). Treatment of Renal Artery Stenosis and Fibromuscular Dysplasia. In: Hoballah, J., Lumsden, A. (eds) Vascular Surgery. New Techniques in Surgery Series, vol 6. Springer, London. https://doi.org/10.1007/978-1-4471-2912-7_14
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2912-7_14
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2911-0
Online ISBN: 978-1-4471-2912-7
eBook Packages: MedicineMedicine (R0)